(Q43819156)

27 November 2017

title

Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide (English)

1 reference

27 November 2017

Robert S Meissner

1

1 reference

27 November 2017

James J Perkins

2

1 reference

27 November 2017

Le T Duong

3

1 reference

27 November 2017

George D Hartman

4

1 reference

27 November 2017

William F Hoffman

5

1 reference

27 November 2017

Joel R Huff

6

1 reference

27 November 2017

Nathan C Ihle

7

1 reference

27 November 2017

Chih Tai Leu

8

1 reference

27 November 2017

Rose M Nagy

9

1 reference

27 November 2017

Adel Naylor-Olsen

10

1 reference

27 November 2017

Gideon A Rodan

11

1 reference

27 November 2017

Sevgi B Rodan

12

1 reference

27 November 2017

David B Whitman

13

1 reference

27 November 2017

Gregg A Wesolowski

14

1 reference

27 November 2017

Mark E Duggan

15

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

number of pages

5

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

25-29

1 reference

Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900687-4

7 January 2021

10.1016/S0960-894X(01)00687-4

Identifiers

DOI

1 reference

27 November 2017

1 reference